IP Focussed

Special Reports

We publish our special reports to help tackle the key questions our clients regularly ask us. We combine our expert knowledge with data driven research to encourage discussion and aid the decision-making process.

Our reports focus on a variety of topics and provide in-depth, data-led analysis and commentary to identify trends and answer critical questions.Designed to offer unique insights our aim is to help businesses make strategic commercial decisions aligned to their goals and objectives in vital areas of IP.

Intelligent Insights to Support Informed Choices

Battery Report Front Cover v2

Battery insights & IP trends

This report demonstrates how innovation is blossoming in all areas of the battery ecosystem driven by both pressures and incentives; and how patents are playing a big part in protecting inventions and forming one branch of a wider commercial strategy.

annie-spratt-ME6iGWqR_zs-unsplash

Challenging patents and other clearance actions in Europe

From post-grant offensive options including EPO oppositions, UKIPO non-binding validity opinions, and revocation actions at the UKIPO, UPC or national courts. To post-grant defensive options including UPC protective letters, UKIPO non-binding infringement opinions, and UPC or national court declarations of non-infringement (DNIs). This brochure covers the lot.

Design Rights report cover image-2

Design Rights: A powerful tool in the IP armoury

This report provides a framework for understanding and leveraging design rights within your intellectual property portfolio. It explores the types and scope of protection offered by design rights, their strategic value, and key considerations for registration and filing location.

Green IP traffic light

Does Green IP mean go? Exploring acceleration under the UKIPO's "Green Channel"

In this report we look at some of the trends in the operation and use of the UK IPO’s Green Channel program and comment on how this can help businesses using, and considering using, the Green Channel going forward.

Blue light trail feature image-1

EPO Opposition Trends in Engineering, Electronics and Software

In autumn 2020, we analysed more than 8000 opposition cases filed at the European Patent Office (EPO) over the last 12 years, studying the timelines for hundreds of engineering, electronics and software oppositions.

Cells under a microscope B&W-1

EPO Opposition Trends in the Life Sciences Sector

In spring 2019, Mewburn Ellis undertook 350 hours of research, analysing more than 5,000 opposition cases filed at the European Patent Office over the last ten years, studying the timelines for hundreds of life sciences oppositions both before and after the EPO’s opposition streamlining initiative.

Femtech Report - Feature Image

Femtech: a growth industry

Our report examines the new technologies that have entered the Femtech market in recent years. As well as the ways in which these developments are providing genuine health benefits to women, from early diagnosis of cancer and improved surgical outcomes to more sustainable period products and options for remote delivery of healthcare. We also look at IP trends in what is a rapidly growing and competitive industry.

Graphene1

Graphene: patenting a wonder material

Our research reveals that graphene innovation has skyrocketed over the last decade, with the construction and energy storage industries seeing the most significant growth. The data suggest three ‘waves’ of graphene innovation, starting from early development at universities through to application in industry and then to results beginning to be realised in the last two to three years.

Newsletter - Header Image - Green IP Report

Green IP

Our report examines the role of patents in making innovative ‘green’ technologies into a reality as well as how the patent landscape can be used to identify opportunities for partnering, collaboration and investment.

Medtech wearble on wrist

How AI is Shaping the Future of MedTech

This report looks into the challenges that arise while patenting MedTech innovations, in particular, uses for AI in the industry.

Antibodies

Innovations in antibody-drug conjugates and bispecific antibodies - what you need to know

The report examines the rise of these key therapeutic technologies which meet the demand for targeted, patient-friendly cancer therapies, and are generating a stream of blockbuster products. It delves into the different aspects of ADC and bsAb innovation, and also looks at global patent filing data to identify trends in the bsAb and ADC intellectual property space.

Women B&W

IP Equality: A collection of articles about Women in IP

This special report is a collection of articles from our Forward magazine, bringing together some of our recent features about brilliant women from the world of IP.

medtech - medical devices report

Medical devices: Insights through IP

This report looks at the recent IP trends in the medical devices sector which has seen significant growth in the rate of innovation in recent years, a lot of which has been driven by ambitious SMEs.

B&W white pills-edit-1

Non-Traditional Pharmaceutical Trade Marks

In this special report, we explore the relevance of each type of non-traditional trade mark to the pharmaceutical sector, how they can be registered and enforced and the particular challenges brands will face along the way. We also explore the difficulties associated with attempts to register smell and taste marks successfully and what the future might hold for non-traditional trade marks in the pharma space.

bioinformatics landmark blog alt

Patent Landscape in Bioinformatics and Digital Health: a data-driven analysis

The words "digital health", "data driven" and "AI" have been on everyone's lips and in many headlines in the healthcare and life sciences sectors over the last couple of years. We set out to collect data on the patent landscape in the fields of bioinformatics and digital health, to see whether the growth we and our clients see in the field is reflected in the data and whether insights can be gained that will assist in designing better, more informed IP strategies.

Litigation Report front cover-compressed

Patent Litigation Trends in England and Wales

This report examines data collected between 1 January 2020 and 1 December 2021 in both the Patents Court and the Intellectual Property Enterprise Court (IPEC). It looks at the types and sizes of businesses that are most frequently filing claims as well as where they are based. It also explores the industries and technical areas where parties tend to operate, and the strategies deployed on both sides of the dispute.

Newsletter - SPC Report Antibody

Pharma and Life Sciences Patent Extensions in Europe

Over 60 countries provide extensions for pharma and life sciences patents – more than half of them in Europe. They’re incredibly important in helping to compensate for the years of delay in getting a product through clinical trials and regulatory reviews.

TM Report front cover-2

Pharma Trade Marks: Exhaustion and Parallel Trade in the UK

This report discusses the complexities of the current trade mark exhaustion landscape, and the outcome of the recent UK government consultation (2021) on Exhaustion and Parallel Trade in the Pharmaceutical Sector.

3D Redner of Quantum Computer

Quantum and the law

The report highlights some of the challenges in commercialising the mysteries of quantum physics. It highlights that business leaders need to tread carefully when it comes to protecting their quantum innovations if they are to maximise their potential.

Newsletter - Software Report

Software Inventions: UKIPO and EPO approaches to patent eligibility

It is well-known that it can be challenging to obtain patent protection for inventions relating to software in Europe. Indeed, it is common for software developers to assume that European patent protection is not available for their innovations.

Newsletter - Header Image Sustainable Communities

Sustainable Communities 2022: The Mewburn Ellis Forward Community Programme

This new report summarises all the work we have done as a firm over the last two years around charity, inclusivity and the environment as well as some of our plans for the future.

Sustainable Communities Report 2023 (Email)

Sustainable Communities 2023: The Mewburn Ellis Forward Community Programme

This Sustainable Communities 2023 Annual Report summarises the progress we have made in the last twelve months since our previous annual report and highlights our tremendous achievements, as well as setting out our plans for 2023-24.

AdobeStock_493727076

Sustainable Communities 2024: The Mewburn Ellis Forward Community Programme

This report summarises the progress we have made in the last twelve months since our previous annual report and highlights our amazing achievements.

The Future of Automotive Special Report Featured Image-1

The Future of Automotive

Find out about the latest key topics and challenges the automotive industry is facing and how innovative businesses are adapting as a result. From how cities are adapting to the electric vehicle revolution and the role of autonomous vehicles, to data security issues in the world of connected cars.

shutterstock_143468515

The IP Guide for the Forward-Looking SME

Whether you are aiming for an exit strategy through investment or acquisition, or to grow and further establish your business, IP can play a key role. Perhaps you have some experience of IP but are you unsure if you're making the most of it? Perhaps you have no experience of IP and would like to understand how you could use it to your advantage?

UPC Image

The Unitary Patent and the Unified Patent Court - a guide

Find out more detail about the Unitary Patent and Unified Patent Court with our detailed guide. This covers a summary overview of both as well as details around costs and processes to obtain a unitary patent and a comparison of pros and cons.

validating european patents outside europe picture (2)-1

Validating European Patents outside Europe - the Validation State System

This report examines the Validation State system, a newer feature of the European Patent (EP) system employing ‘Validation Agreements’ and looks at usage and awareness of the system.

SPCs B&W-2

Validation Strategies for Pharmaceutical Patents in Europe

The decision on where to validate a pharmaceutical European patent is a big one. With costs often precluding an “everywhere” approach for small- to medium-sized companies, research institutions and universities, it is necessary to choose from the long list of available countries.

"Our specialists ensure you benefit from 'joined up' thinking when it comes to your IP strategy and work alongside you to support your business ambitions and growth plans".

Forward Magazines Overlapping 8

Mewburn Ellis

FORWARD MAGAZINE

Mewburn Ellis Forward is a biannual publication that celebrates the best of innovation and exploration. Through its pages we hope to inform and entertain, but also to encourage discussion about the most compelling developments taking place in the scientific and entrepreneurial world. Along the way, we’ll engage with the IP challenges that international organisations face every day.

Subscribe now